Overview

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

Summary

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Dr. Reddy's Laboratories Limited

Treatments:

Amlodipine
Benazepril